Increased mortality in ankylosing spondylitis is related to disease activity

Annals of the Rheumatic Diseases

Volumn 70, Issue 11, 2011, Pages 1921-1925

  Bakland, Gunnstein ^a   Gran, Jan Tore ^b   Nossent, Johannes C ^a  

^a UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL;

ADULT; ANKYLOSING SPONDYLITIS; ARTICLE; CANCER MORTALITY; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; COHORT ANALYSIS; CONTROLLED STUDY; DELAYED DIAGNOSIS; DISEASE ACTIVITY; FEMALE; HUMAN; INFECTION; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MORTALITY; MULTIVARIATE ANALYSIS; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEX DIFFERENCE; STANDARDIZATION; SURVIVAL; SURVIVAL TIME; WORK DISABILITY;

ADOLESCENT; ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; DELAYED DIAGNOSIS; DISABILITY EVALUATION; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; MALE; NEOPLASMS; NORWAY; OPPORTUNISTIC INFECTIONS; SEX FACTORS; SPONDYLITIS, ANKYLOSING; YOUNG ADULT;

EID: 80053569408     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/ard.2011.151191     Document Type: Article

References (29)

1. Brown WM, Doll R. Mortality from cancer and other causes after radiotherapy for ankylosing spondylitis. BMJ 1965;2:1327-32.
2. Radford EP, Doll R, Smith PG. Mortality among patients with ankylosing spondylitis not given X-ray therapy. N Engl J Med 1977;297:572-6. (Pubitemid 8197336)
3. Lehtinen K. Mortality and causes of death in 398 patients admitted to hospital with ankylosing spondylitis. Ann Rheum Dis 1993;52:174-6. (Pubitemid 23094303)
4. Myllykangas-Luosujärvi R, Aho K, Lehtinen K, et al. Increased incidence of alcohol-related deaths from accidents and violence in subjects with ankylosing spondylitis. Br J Rheumatol 1998;37:688-90.
5. Khan MA, Khan MK, Kushner I. Survival among patients with ankylosing spondylitis: a life-table analysis. J Rheumatol 1981;8:86-90. (Pubitemid 11118467)
6. Zochling J, Braun J. Mortality in ankylosing spondylitis. Clin Exp Rheumatol 2008;26 (5 Suppl 51):S80-4.
7. Khan MA. Update on spondyloarthropathies. Ann Intern Med 2002;136:896-907. (Pubitemid 34625702)
8. Bakland G, Gran JT, Becker-Merok A, et al. Work disability in patients with ankylosing spondylitis in Norway. J Rheumatol 2011;38:479-84.
9. Bakland G, Nossent HC, Gran JT. Incidence and prevalence of ankylosing spondylitis in Northern Norway. Arthritis Rheum 2005;53:850-5. (Pubitemid 41811125)
10. van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 1984;27:361-8. (Pubitemid 14134775)
11. Nakajima A, Inoue E, Tanaka E, et al. Mortality and cause of death in Japanese patients with rheumatoid arthritis based on a large observational cohort, IORRA. Scand J Rheumatol 2010;39:360-7.
12. Kaprove RE, Little AH, Graham DC, et al. Ankylosing spondylitis: survival in men with and without radiotherapy. Arthritis Rheum 1980;23:57-61. (Pubitemid 10214770)
13. Becker-Merok A, Nossent J. Prevalence, predictors and outcome of vascular damage in systemic lupus erythematosus. Lupus 2009;18:508-15.
14. Watson DJ, Rhodes T, Guess HA. All-cause mortality and vascular events among patients with rheumatoid arthritis, osteoarthritis, or no arthritis in the UK General Practice Research Database. J Rheumatol 2003;30:1196-202. (Pubitemid 36666340)
15. Gladman DD. Mortality in psoriatic arthritis. Clin Exp Rheumatol 2008;26 (5 Suppl 51):S62-5.
16. Roldan CA, Chavez J, Wiest PW, et al. Aortic root disease and valve disease associated with ankylosing spondylitis. J Am Coll Cardiol 1998;32:1397-404. (Pubitemid 28522401)
17. Hollan I, Saatvedt K, Almdahl SM, et al. Spondyloarthritis: a strong predictor of early coronary artery bypass grafting. Scand J Rheumatol 2008;37:18-22.
18. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005;352:1685-95.
19. Morrow DA, Ridker PM. C-reactive protein, inflammation, and coronary risk. Med Clin North Am 2000;84:149-61, ix. (Pubitemid 30068896)
20. van der Heijde D, Lie E, Kvien TK, et al. ASDAS, a highly discriminatory ASAS-endorsed disease activity score in patients with ankylosing spondylitis. Ann Rheum Dis 2009;68:1811-18.
21. Dik VK, Peters MJ, Dijkmans PA, et al. The relationship between disease-related characteristics and conduction disturbances in ankylosing spondylitis. Scand J Rheumatol 2010;39:38-41.
22. Fosbøl EL, Køber L, Torp-Pedersen C, et al. Cardiovascular safety of non-steroidal anti-inflammatory drugs among healthy individuals. Expert Opin Drug Saf 2010;9:893-903.
23. Goodson NJ, Brookhart AM, Symmons DP, et al. Non-steroidal anti-inflammatory drug use does not appear to be associated with increased cardiovascular mortality in patients with inflammatory polyarthritis: results from a primary care based inception cohort of patients. Ann Rheum Dis 2009;68:367-72.
24. Peters MJ, van der Horst-Bruinsma IE, Dijkmans BA, et al. Cardiovascular risk profile of patients with spondylarthropathies, particularly ankylosing spondylitis and psoriatic arthritis. Semin Arthritis Rheum 2004;34:585-92. (Pubitemid 39643120)
25. van Halm VP, van Denderen JC, Peters MJ, et al. Increased disease activity is associated with a deteriorated lipid profile in patients with ankylosing spondylitis. Ann Rheum Dis 2006;65:1473-7. (Pubitemid 44629125)
26. van Eijk IC, Peters MJ, Serné EH, et al. Microvascular function is impaired in ankylosing spondylitis and improves after tumour necrosis factor alpha blockade. Ann Rheum Dis 2009;68:362-6.
27. Appel H, Kuhne M, Spiekermann S, et al. Immunohistologic analysis of zygapophyseal joints in patients with ankylosing spondylitis. Arthritis Rheum 2006;54:2845-51. (Pubitemid 44497763)
28. Cambridge B, Cina SJ. The accuracy of death certificate completion in a suburban community. Am J Forensic Med Pathol 2010;31:232-5.
29. Calvo-Alén J, Alarcón GS, Campbell R, Jr, et al. Lack of recording of systemic lupus erythematosus in the death certificates of lupus patients. Rheumatology (Oxford) 2005;44:1186-9. (Pubitemid 41236029)